Cholinergic Pharmacology

Correct Answer

B — Presynaptic neurotoxin that blocks acetylcholine release

Explanation

Botulinum toxin is classified as a presynaptic neurotoxin. It acts at the nerve terminal to block the release of acetylcholine into the synaptic cleft, which is the defining categorical feature of this agent.

Correct Answer

D — Partial agonist at alpha-4 beta-2 nicotinic acetylcholine receptors

Explanation

Varenicline is classified as a partial agonist at alpha-4 beta-2 nicotinic acetylcholine receptors, the primary site of nicotine action in the brain. Partial agonism at this receptor subtype is the defining pharmacological classification of varenicline and the basis for its use in smoking cessation.

Correct Answer

A — Depolarizing neuromuscular blocking agent

Explanation

Succinylcholine is a depolarizing neuromuscular blocking agent. It binds and activates nicotinic receptors at the neuromuscular junction, holding the endplate in a depolarized state. This class distinction separates succinylcholine from non-depolarizing agents such as rocuronium and vecuronium, which act by competitive antagonism.

Correct Answer

C — Reversible acetylcholinesterase inhibitor

Explanation

Neostigmine is classified as a reversible acetylcholinesterase inhibitor. It inhibits the enzyme that breaks down acetylcholine at cholinergic synapses, allowing acetylcholine to accumulate and produce a more sustained effect.

Correct Answer

A — Muscarinic receptor antagonist

Explanation

Atropine is classified as a muscarinic receptor antagonist. It competitively blocks all five muscarinic receptor subtypes, which is the defining categorical label for this agent and the basis for its clinical applications.

Correct Answer

C — Non-depolarizing neuromuscular blocking agents

Explanation

Rocuronium and vecuronium are non-depolarizing neuromuscular blocking agents. This class acts by competitive antagonism at nicotinic receptors at the neuromuscular junction, preventing acetylcholine from opening the ion channel and blocking muscle contraction. Non-depolarizing blockade is reversible with acetylcholinesterase inhibitors, distinguishing this class from depolarizing agents such as succinylcholine.

Correct Answer

C — Enzymatic hydrolysis by acetylcholinesterase in the synaptic cleft

Explanation

Acetylcholine is unique among major neurotransmitters in that its action is terminated entirely by enzymatic hydrolysis rather than reuptake of the intact molecule. Acetylcholinesterase in the synaptic cleft rapidly breaks acetylcholine down into choline and acetate. Because termination depends entirely on this enzyme, inhibiting acetylcholinesterase prolongs and amplifies cholinergic signaling simultaneously at every site where acetylcholine is released.

Correct Answer

A — Odd-numbered subtypes (M1, M3, M5) couple to Gq; even-numbered subtypes (M2, M4) couple to Gi

Explanation

Muscarinic receptor subtypes follow a consistent odd-even coupling pattern. The odd-numbered subtypes — M1, M3, and M5 — couple to Gq proteins, activating pathways that raise intracellular calcium and produce excitatory responses. The even-numbered subtypes — M2 and M4 — couple to Gi proteins, reducing cellular excitability. This pattern organizes the entire muscarinic receptor family and predicts the downstream effects of subtype-selective drugs.

Correct Answer

D — Rocuronium carries a permanent positive charge and cannot cross the blood-brain barrier

Explanation

Rocuronium and other non-depolarizing neuromuscular blocking agents are quaternary ammonium compounds, meaning they carry a permanent positive charge at physiological pH. Charged molecules cannot cross lipid membranes, including the blood-brain barrier. This structural property confines their action to peripheral sites — the neuromuscular junction and autonomic ganglia — with no central nervous system effects at therapeutic doses.

Correct Answer

B — It transfers an acetyl group from acetyl coenzyme A to choline, producing acetylcholine in the nerve terminal

Explanation

Choline acetyltransferase catalyzes the synthesis of acetylcholine by transferring an acetyl group from acetyl coenzyme A to choline inside the nerve terminal. This reaction is the defining biochemical marker of cholinergic neurons. The enzyme is present in the cytoplasm of cholinergic nerve terminals, where newly synthesized acetylcholine is then packaged into synaptic vesicles.

Correct Answer

A — They block nicotinic receptors at both sympathetic and parasympathetic ganglia simultaneously, eliminating all autonomic regulation

Explanation

Ganglionic blocking agents such as hexamethonium block nicotinic receptors at autonomic ganglia, which are shared by both sympathetic and parasympathetic divisions. Because both divisions use nicotinic transmission at the ganglionic synapse, these drugs interrupt all autonomic regulation simultaneously. The result is a predictable syndrome reflecting loss of both divisions: profound orthostatic hypotension from loss of sympathetic tone, tachycardia from loss of vagal tone, and dry mouth, mydriasis, and urinary retention from loss of parasympathetic tone.

Correct Answer

C — Nicotinic receptors are ligand-gated ion channels that open within milliseconds of acetylcholine binding; muscarinic receptors are G-protein-coupled receptors with slower signaling

Explanation

Nicotinic acetylcholine receptors are ligand-gated ion channels. When acetylcholine binds, the channel opens directly within milliseconds, allowing sodium and calcium influx that depolarizes the membrane. Muscarinic receptors are G-protein-coupled receptors that activate intracellular signaling cascades with a slower onset. This fundamental difference in signal transduction mechanism — ion channel versus G-protein — explains the rapid speed of nicotinic responses at the neuromuscular junction and autonomic ganglia compared to the slower, more sustained effects of muscarinic receptor activation.

Correct Answer

B — Autoimmune antibodies destroy nicotinic receptors at the neuromuscular junction, reducing the safety margin for neuromuscular transmission

Explanation

In myasthenia gravis, autoimmune antibodies target and destroy nicotinic acetylcholine receptors at the neuromuscular junction endplate. With fewer receptors available, the endplate potential generated by each nerve impulse is smaller, reducing the safety margin for triggering a muscle action potential. Weakness worsens with repeated use because repeated firing further depletes the functional receptor pool, and recovers with rest as the endplate potential has time to recover.

Correct Answer

D — Atropine blocks muscarinic M2 receptors at the sinoatrial node, removing the vagal brake on heart rate

Explanation

The sinoatrial node is under continuous vagal inhibition mediated by acetylcholine acting on muscarinic M2 receptors. M2 receptor activation couples to Gi proteins, slowing sinoatrial node depolarization and reducing heart rate. Atropine competitively blocks M2 receptors, removing this vagal brake and allowing the sinoatrial node to fire at a faster intrinsic rate. The result is an increase in heart rate proportional to the degree of resting vagal tone that was present before atropine was given.

Correct Answer

A — Blockade of muscarinic receptors at exocrine glands, smooth muscle, the eye, and the brain

Explanation

The clinical picture — hyperthermia, dry flushed skin, dilated unreactive pupils, urinary retention, and acute confusion — is the anticholinergic syndrome. It results from competitive blockade of muscarinic receptors at all target organs simultaneously. Blockade of muscarinic receptors on eccrine sweat glands prevents heat dissipation, causing hyperthermia. Blockade of the iris sphincter causes mydriasis. Blockade of the detrusor causes urinary retention. Blockade of central nervous system muscarinic receptors produces the confusion and agitation, which is especially pronounced in elderly patients.

Correct Answer

C — It inhibits acetylcholinesterase, slowing the breakdown of acetylcholine at synapses in the cortex and hippocampus to partially compensate for the loss of cholinergic neurons

Explanation

Alzheimer disease is characterized by progressive loss of cholinergic neurons projecting from the basal forebrain to the cerebral cortex and hippocampus, reducing acetylcholine availability in regions that mediate memory and cognition. Donepezil inhibits acetylcholinesterase, the enzyme that breaks down acetylcholine at cholinergic synapses. By slowing acetylcholine breakdown, donepezil increases the duration and concentration of acetylcholine at remaining synapses, partially compensating for the neuronal loss.

Correct Answer

D — As a partial agonist at alpha-4 beta-2 nicotinic receptors, it provides enough stimulation to reduce craving while competitively blocking the full response to inhaled nicotine

Explanation

Varenicline is a partial agonist at alpha-4 beta-2 nicotinic acetylcholine receptors, the primary site of nicotine action in the brain's reward pathway. Partial agonism provides sufficient receptor activation to reduce the craving and withdrawal symptoms that drive relapse, while simultaneously occupying the receptor and blocking the larger agonist response that inhaled nicotine would otherwise produce. This dual action explains both effects the patient describes: reduced craving from partial stimulation and reduced satisfaction from competitive blockade of nicotine.

Correct Answer

B — Succinylcholine produces depolarizing block, and accumulation of acetylcholine at an already depolarized endplate deepens rather than reverses the block

Explanation

Succinylcholine produces neuromuscular blockade by activating nicotinic receptors at the endplate and holding them in a persistently depolarized state. Neostigmine inhibits acetylcholinesterase, causing acetylcholine to accumulate — but at an endplate already in a depolarized block, additional acetylcholine worsens the block rather than reversing it. This is the fundamental difference between depolarizing and non-depolarizing blockade: non-depolarizing block is reversed by acetylcholine accumulation because the two compete for the receptor, but depolarizing block is worsened by it.